Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?

Table 5

G-peak sl ap lax, G peak sl a2c, G peak sl a4c, and G peak sl avg in group I and group II.

Tissue		𝑁	Range	Mean	±SD	t-test	P value
G peak sl ap lax	Group I	12	−7–−20	−12.08	5.36	4.922	0.001**
	Group II	12	−16–−24	−20.50	2.50
G peak sl a4c	Group I	12	−4–−20	−11.91	5.35	2.042	<0.05*
	Group II	12	−10–−23	−15.41	2.574
G peak sl a2c	Group I	12	−9–−19	−14	6.53	4.227	0.001**
	Group II	12	−15–−25	−24.2	5.27
Peak sl avg	Group I	12	−6–−19	−12.25	5.62	2.585	<0.05*
	Group II	12	−18–−24	−18.41	6.05

**Highly significant, *Significant.